{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:34:58Z","timestamp":1790372098473,"version":"4.1.0"},"reference-count":30,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T00:00:00Z","timestamp":1512950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology International"],"abstract":"<jats:p>To study the impact of depression and anxiety on health-related quality of life (HRQOL) in patients with multiple sclerosis (pwMS) in the UAE. All consecutive patients attending the MS clinic over a fourmonth period, October 2014 through February 2015, at Sheikh Khalifa Medical city (SKMC) were asked to complete The World Health Organization quality of life abbreviated scale (WHOQOL-BREF), the Patient Health Questionnaire nine-item (PHQ-9) depression scale, and Generalized Anxiety Disorder seven-item (GAD-7) scale. These last two scales were used to screen for depression and anxiety disorders respectively. The study looked at significant variables associated with HRQOL, using multivariate analysis. Eighty patients were enrolled in the study. Both anxiety and depression had a strong positive correlation with HRQOL in univariate analysis. However, depression was the strongest predictor of HRQOL in the patients using linear multi-regression analysis. Screening and timely treatment of both anxiety and depression in MS patients should be a recommended policy when managing pwMS to improve their optimal care and ensure better quality of life.<\/jats:p>","DOI":"10.4081\/ni.2017.7343","type":"journal-article","created":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T12:21:52Z","timestamp":1521807712000},"page":"7343","source":"Crossref","is-referenced-by-count":21,"title":["Depression and Anxiety as Determinants of Health-Related Quality of Life in Patients with Multiple Sclerosis - United Arab Emirates"],"prefix":"10.3390","volume":"9","author":[{"given":"Taoufik","family":"Alsaadi","sequence":"first","affiliation":[{"name":"American Center for Psychiatry and Neurology, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"El Hammasi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Sheikh Khalifa Medical City (SKMC), Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek M.","family":"Shahrour","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Sheikh Khalifa Medical City (SKMC), Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Shakra","sequence":"additional","affiliation":[{"name":"American Center for Psychiatry and Neurology, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamya","family":"Turkawi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim","family":"Nasreddine","sequence":"additional","affiliation":[{"name":"Department of Neurology, American University of Beirut-Medical Center, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seada","family":"Kassie","sequence":"additional","affiliation":[{"name":"American Center for Psychiatry and Neurology, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mufeed","family":"Raoof","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Sheikh Khalifa Medical City (SKMC), Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,12,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1177\/1352458514543344","article-title":"Psychiatric comorbidity in multiple sclerosis: It\u2019s not the genes","volume":"20","year":"2014","journal-title":"Mult Scler J"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1756285608100325","article-title":"Psychopathology in Multiple Sclerosis: Diagnosis, prevalence, and treatment","volume":"2","author":"Haussleiter","year":"2009","journal-title":"Ther Adv Neurol Disord"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/1352458514564487","article-title":"The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review","volume":"21","author":"Anne","year":"2015","journal-title":"Mult Scler J"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/1352458515588973","article-title":"Psychiatric comorbidity in multiple sclerosis: The risk of depression and anxiety before and after MS diagnosis","volume":"22","author":"Huang","year":"2016","journal-title":"Mult Scler J"},{"key":"ref_5","first-page":"593","article-title":"Quality of life in Multiple Sclerosis (MS), and role of fatigue, depression, anxiety, and stress: A bi-center study from North of Iran","volume":"19","author":"Salephoor","year":"2014","journal-title":"Iran J Nurs Midwifery Res"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e41910","DOI":"10.1371\/journal.pone.0041910","article-title":"A large-scale study of anxiety and depression in people with multiple sclerosis: A survey via the web portal of the UK MS Register","volume":"7","author":"Jones","year":"2012","journal-title":"PLoS One"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1023\/A:1020734901150","article-title":"Quality of life and multiple sclerosis: Comparison between people with multiple sclerosis and people from the general population","volume":"9","author":"McCabe","year":"2002","journal-title":"J Clin Psychol Med Settings"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1212\/WNL.0000000000002564","article-title":"Health-related quality of life in multiple sclerosis: direct and indirect effects of comorbidity","volume":"86","author":"Berrigan","year":"2016","journal-title":"Neurology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7224\/1537-2073.2015-013","article-title":"Associations between MS and disability, functional mobility, depression, and quality of life in people with multiple sclerosis","volume":"18","author":"Garg","year":"2016","journal-title":"Int J MS Care"},{"key":"ref_10","first-page":"279","article-title":"Quality of life and multiple sclerosis","volume":"51","author":"Olascoaga","year":"2010","journal-title":"Rev Neurol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.59.5.674","article-title":"An examination of suicidal intent in patients with multiple sclerosis","volume":"59","author":"Feinstein","year":"2002","journal-title":"Neurol"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2165\/00023210-200822100-00004","article-title":"Health-related quality of life in multiple sclerosis: Current evidence, measurement and effects of disease severity and treatment","volume":"22","author":"Rudick","year":"2008","journal-title":"CNS Drugs"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/ene.12046","article-title":"Predictors of quality of life among multiple sclerosis patents: a comprehensive analysis","volume":"20","author":"Yamout","year":"2013","journal-title":"Eur J Neurol"},{"key":"ref_14","first-page":"1291","article-title":"A review of the impact of multiple sclerosis on healthrelated quality of life","volume":"25","author":"Gonzalez","year":"2005","journal-title":"Disabil Rehabil"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrneurol.2014.139","article-title":"The link between multiple sclerosis and depression","volume":"10","author":"Feinstein","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1590\/S0004-282X2010000500010","article-title":"Maintaining quality of life in multiple sclerosis: Fact, fiction, or limited reality?","volume":"5","author":"Vasconcelos","year":"2010","journal-title":"Arq Neurops"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11136-012-0129-3","article-title":"Health related quality of life measures in Arabic speaking populations: A systematic review on crosscultural adaptation & measurement properties","volume":"22","author":"Al","year":"2013","journal-title":"Qual Life Res"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.genhosppsych.2005.07.003","article-title":"Validity of the brief Patient Health Questionnaire mood scale (PHQ-9) in the general population","volume":"28","author":"Martin","year":"2006","journal-title":"Gen Hosp Psychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MLR.0b013e318160d093","article-title":"Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population","volume":"46","author":"Lowe","year":"2008","journal-title":"Med Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11136-004-0787-x","article-title":"Cntent validity, construct validity, and reliability of the WHOQOL-Bref in a population of Dutch adult psychiatric outpatients","volume":"14","author":"Trompenaars","year":"2005","journal-title":"Qual Life Res"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic Criteria for multiple Sclerosis","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/09638280500191753","article-title":"Depression is the main determinant of quality of life in multiple sclerosis: a classification-regression (CART) study","volume":"28","author":"Miscio","year":"2006","journal-title":"Disabil Rehabil"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1034\/j.1600-0404.2001.00022.x","article-title":"Depression and quality of life in multiple sclerosis","volume":"104","author":"Fruehwald","year":"2001","journal-title":"Acta Neurol Scand"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1191\/1352458503ms930oa","article-title":"Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis","volume":"9","author":"Janssens","year":"2003","journal-title":"Mult Scler"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10198-006-0384-8","article-title":"Costs and quality of life for patients with multiple sclerosis in Germany","volume":"7","author":"Kobelt","year":"2006","journal-title":"Eur J Health Econ"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/bmj.314.7094.1580","article-title":"Doctors and patients don\u2019t agree: Cross-sectional study of patients\u2019 and doctors\u2019 perceptions and assessments of disability in multiple sclerosis","volume":"314","author":"Rothwell","year":"1997","journal-title":"Br Med J"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/09638280010022090","article-title":"Health status and quality of life of people with multiple sclerosis","volume":"23","author":"Ford","year":"2001","journal-title":"Disabil Rehabil"},{"key":"ref_28","first-page":"487159","article-title":"Prevalence of depression and anxiety among patients with multiple sclerosis attending the MS clinic at Sheikh Khalifa Medical City, UAE: Cross-sectional study","volume":"2015","author":"Alsaadi","year":"2015","journal-title":"Mult Scler Int"},{"key":"ref_29","unstructured":"(2001). International classification of functioning, disability, and health-ICF. Prague Med Rep, 109, 268\u201374."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1177\/1352458508091260","article-title":"The impact of disabilities on quality of life in people with multiple sclerosis","volume":"14","author":"Wynia","year":"2008","journal-title":"Mult Scler"}],"container-title":["Neurology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/ni\/article\/viewFile\/7343\/7148","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/ni\/article\/viewFile\/7343\/7275","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.mdpi.com\/2035-8377\/9\/4\/7343\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T14:40:06Z","timestamp":1688395206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2035-8377\/9\/4\/7343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,11]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["ni.2017.7343"],"URL":"https:\/\/doi.org\/10.4081\/ni.2017.7343","relation":{},"ISSN":["2035-8377"],"issn-type":[{"value":"2035-8377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,11]]}}}